Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Urology · Benign Prostatic Hyperplasia

How Do Tamsulosin, Alfuzosin, and Silodosin Compare?

At a Glance

Tamsulosin, alfuzosin, and silodosin usually improve BPH urinary symptoms to a similar degree, so the best choice depends on side-effect priorities, other medicines, kidney and liver health, dosing needs, and planned cataract surgery.

Alpha-blockers like tamsulosin, alfuzosin, and silodosin are highly effective at relieving the urinary symptoms of a noncancerous enlargement of the prostate (benign prostatic hyperplasia or BPH) [1]. While they have similar average efficacy, individual responses can vary, and no single medication is universally the “best” [2]. The right choice for you depends on your side-effect priorities, kidney and liver function, and other medications you take—especially those for high blood pressure [3].

How Alpha-Blockers Work

Tamsulosin, alfuzosin, and silodosin are alpha-1 adrenergic receptor antagonists. They work by relaxing the smooth muscle in the prostate and the bladder neck [4]. This reduces resistance against urine flowing out of the bladder, making it easier to urinate [5].

These medications do not cure BPH, nor do they shrink the prostate gland [6]. If you have a substantially enlarged prostate, your doctor may suggest adding a different type of medication (like a 5-alpha-reductase inhibitor) to actually shrink the gland. Overall, studies show that by 12 weeks of treatment, these three alpha-blockers provide broadly similar improvements in urinary symptoms [2].

Comparing the Side Effects

Because these drugs are broadly similar in how well they improve urine flow, doctors and patients usually choose between them based on their different side-effect profiles.

Dizziness and Blood Pressure Drops

Because alpha-blockers relax smooth muscle, they can also relax blood vessels, leading to orthostatic hypotension—a sudden drop in blood pressure when you stand up [7]. This can cause dizziness, lightheadedness, or fainting.

Older adults face a notably higher risk of falls and fractures in the first 90 days after starting an alpha-blocker [7]. If you take medications for high blood pressure (like lisinopril) or for erectile dysfunction (like sildenafil or tadalafil), you must use caution, as combining these can cause dangerous blood pressure drops [3].

Safety Tip: Always rise slowly from a sitting or lying position. If you experience severe lightheadedness or fainting, or if you are unable to urinate, contact your doctor immediately.

Ejaculatory Changes

These medications can cause anejaculation (or a “dry orgasm”), meaning little to no semen comes out during climax [8]. This is usually caused by a failure of the body to emit semen, rather than semen going backward into the bladder [9][10]. This side effect usually goes away if you stop taking the medication, and it does not typically prevent you from having an erection or reaching an orgasm [11].

  • Silodosin has the highest risk of ejaculatory changes, with many men experiencing a loss of semen emission [11].
  • Tamsulosin carries a moderate risk of reduced or absent ejaculation [12].
  • Alfuzosin has the lowest risk of ejaculatory dysfunction among the three and is often preferred by men who want to preserve normal ejaculation [11].

Cataract Surgery Complications

If you need cataract surgery, taking an alpha-blocker requires special attention. These medications can cause Intraoperative Floppy Iris Syndrome (IFIS), a condition where the iris becomes floppy and complicates the surgery [13].

Tamsulosin has the strongest documented link to severe IFIS, but both alfuzosin and silodosin have also been associated with it [14]. The risk of IFIS does not reliably go away if you stop the medication; it has been observed in patients up to three years after stopping tamsulosin [15].

Do not stop taking your alpha-blocker on your own if you have an upcoming surgery. Instead, tell your eye surgeon if you have ever taken one of these medications. The surgeon can usually proceed with the operation by preparing specific techniques and tools to keep the procedure safe [16].

Dosing, Food, and Organ Function

The way your body processes these medications can be affected by food, other drugs, and your overall organ health. For example, strong inhibitors of the CYP3A4 liver enzyme (like the antifungal ketoconazole) can drastically increase the levels of these alpha-blockers in your blood, making side effects much worse [17]. You should never combine an alpha-blocker with another alpha-blocker or an erectile dysfunction medication without strict prescriber guidance.

Your kidney and liver health also play a role in drug selection. For instance, studies show tamsulosin clearance is generally not affected by renal or liver function parameters [18]. However, your doctor will review your specific kidney and liver health to determine if dose reductions or restrictions are required for other alpha-blockers.

Feature Tamsulosin Alfuzosin Silodosin
How to take it Usually taken 30 minutes after the same meal each day [19]. Extended-release pill taken immediately after the same meal each day. Do not crush [19]. Taken once a day with a meal [19].
Ejaculation changes Moderate risk of reduced or absent semen [12]. Lowest risk of ejaculation changes [11]. Highest risk of reduced or absent semen [11].
Cataract surgery (IFIS) Highest documented risk [13]. Known risk [14]. Known risk [14].

Choosing the right medication is a shared decision. By weighing your specific symptoms against your lifestyle priorities—such as avoiding dizziness, preserving sexual function, or planning for eye surgery—you and your doctor can find the option that fits you best.

Common questions in this guide

Do tamsulosin, alfuzosin, and silodosin work equally well for BPH?
On average, all three medicines provide broadly similar improvement in BPH urinary symptoms by about 12 weeks. People can respond differently, so the choice often depends on side effects, other medicines, organ health, and personal priorities.
Which BPH alpha-blocker is least likely to affect ejaculation?
Alfuzosin has the lowest risk of ejaculation changes among the three, while silodosin has the highest and tamsulosin has an intermediate risk. These changes usually go away after the medicine is stopped and generally do not prevent an erection or orgasm.
Can these medicines cause dizziness or low blood pressure?
Yes. Tamsulosin, alfuzosin, and silodosin can lower blood pressure when you stand, causing lightheadedness or fainting. The risk may be higher with blood-pressure medicines or erectile-dysfunction medicines, so rise slowly and contact a clinician immediately for severe lightheadedness or fainting.
What should I tell my eye surgeon if I take an alpha-blocker?
Tell the eye surgeon if you currently take or have ever taken tamsulosin, alfuzosin, or silodosin before cataract surgery. These medicines can contribute to floppy iris syndrome during surgery, and the risk may persist after stopping, especially with tamsulosin. Do not stop the medicine on your own; the surgeon can plan appropriate precautions.
How should I take tamsulosin, alfuzosin, or silodosin with food?
Tamsulosin is usually taken 30 minutes after the same meal each day, while extended-release alfuzosin is taken immediately after the same meal and should not be crushed. Silodosin is taken once daily with a meal. Follow the instructions on your prescription because the exact formulation and dose matter.
Can I take an alpha-blocker with sildenafil, tadalafil, or another alpha-blocker?
Combining an alpha-blocker with another alpha-blocker or an erectile-dysfunction medicine can cause a dangerous drop in blood pressure. Do not combine them unless the prescriber gives specific instructions and explains how to use and monitor the medicines.

Get notified when new evidence is published on prostatic adenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Influence of alpha-adrenoceptor antagonists therapy on stool form in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

    Matsumoto S, Kasamo S, Hashizume K

    Lower urinary tract symptoms 2020; (12(1)):86-91 doi:10.1111/luts.12289.

    PMID: 31464384
  2. 2

    A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia.

    Manjunatha R, Pundarikaksha HP, Madhusudhana HR, et al.

    Indian journal of pharmacology 2016; (48(2)):134-40 doi:10.4103/0253-7613.178825.

    PMID: 27127315
  3. 3

    Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis.

    Mari A, Antonelli A, Cindolo L, et al.

    Therapeutic advances in urology 2021; (13()):1756287221993283 doi:10.1177/1756287221993283.

    PMID: 33912246
  4. 4

    Effect of α-receptor blockers on lower urinary tract symptoms, sexual function and quality of life in young and middle-aged men with benign prostatic hyperplasia.

    Wang T, Wang L, Liang Y, et al.

    Experimental and therapeutic medicine 2017; (14(1)):587-592 doi:10.3892/etm.2017.4518.

    PMID: 28672971
  5. 5

    α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.

    Fusco F, Palmieri A, Ficarra V, et al.

    European urology 2016; (69(6)):1091-101.

    PMID: 26831507
  6. 6

    Short-term Effect of Tamsulosin and Finasteride Monotherapy and their Combination on Nigerian Men with Benign Prostatic Hyperplasia.

    Odusanya BO, Tijani KH, Jeje EA, et al.

    Nigerian journal of surgery : official publication of the Nigerian Surgical Research Society 2017; (23(1)):5-10 doi:10.4103/1117-6806.199963.

    PMID: 28584504
  7. 7

    The risk of fall and fracture with the initiation of a prostate-selective α antagonist: a population based cohort study.

    Welk B, McArthur E, Fraser LA, et al.

    BMJ (Clinical research ed.) 2015; (351()):h5398 doi:10.1136/bmj.h5398.

    PMID: 26502947
  8. 8

    Changing Aspects of Male Sexual Functions Accompanying Treatment of Benign Prostatic Hyperplasia With Silodosin 8 mg Per Day.

    , Cihan A, Kazaz İO, et al.

    The journal of sexual medicine 2020; (17(6)):1094-1100 doi:10.1016/j.jsxm.2020.02.023.

    PMID: 32217036
  9. 9

    Single-dose Tamsulosin Induces Reversible Azoospermia and Ejaculatory Dysfunction Suggesting Potential for on-demand Male Contraception.

    Lopes LS, Candelaria JD, Glina FPA, et al.

    International braz j urol : official journal of the Brazilian Society of Urology 2026; (52(3)).

    PMID: 41770987
  10. 10

    Characteristics of α1-adrenoceptor antagonists-induced ejaculatory dysfunction on spontaneous seminal emission in rats.

    Yoshizumi M, Ise SN, Yonezawa A, et al.

    Basic & clinical pharmacology & toxicology 2024; (134(5)):704-711 doi:10.1111/bcpt.13993.

    PMID: 38409579
  11. 11

    Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis.

    Bapir R, Bhatti KH, Eliwa A, et al.

    Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica 2022; (94(2)):252-263 doi:10.4081/aiua.2022.2.252.

    PMID: 35775356
  12. 12

    Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

    Jung JH, Kim J, MacDonald R, et al.

    The Cochrane database of systematic reviews 2017; (11()):CD012615 doi:10.1002/14651858.CD012615.pub2.

    PMID: 29161773
  13. 13

    Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases.

    Wang YH, Huang LC, Tsai SHL, et al.

    Frontiers in medicine 2022; (9()):941130 doi:10.3389/fmed.2022.941130.

    PMID: 36111121
  14. 14

    Silodosin as a predisposing factor of intraoperative floppy iris syndrome (IFIS): an observational propensity score-matching cohort study.

    Christou CD, Kourouklidou M, Mataftsi A, et al.

    International ophthalmology 2022; (42(2)):393-399 doi:10.1007/s10792-021-02054-y.

    PMID: 34609669
  15. 15

    [Intraoperative floppy iris syndrom (IFIS) associated with tamsulosin].

    Bigdon E, Casagrande M, Spitzer MS, Hassenstein A

    Aktuelle Urologie 2022; (53(3)):246-253 doi:10.1055/a-1199-6900.

    PMID: 33694138
  16. 16

    Floppy iris syndrome and cataract surgery.

    Enright JM, Karacal H, Tsai LM

    Current opinion in ophthalmology 2017; (28(1)):29-34 doi:10.1097/ICU.0000000000000322.

    PMID: 27653607
  17. 17

    [How to act when an alpha-blocker is associated with a potent inhibitor of CYP3A4].

    Bensalah N, Garcia S, Rose FX, et al.

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2017; (27(5)):275-282 doi:10.1016/j.purol.2017.02.003.

    PMID: 28365198
  18. 18

    Population pharmacokinetics of tamsulosine in patients with benign prostatic hyperplasia.

    Nikolic VN, Jankovic SM, Vujovic M, et al.

    World journal of urology 2024; (42(1)):427 doi:10.1007/s00345-024-05115-w.

    PMID: 39037497
  19. 19

    Interactions between medications employed in treating benign prostatic hyperplasia and food - A short review.

    Paśko P, Rodacki T, Domagała-Rodacka R, Owczarek D

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2016; (83()):1141-1145 doi:10.1016/j.biopha.2016.08.021.

    PMID: 27551761

This comparison of tamsulosin, alfuzosin, and silodosin for BPH is for informational purposes only and does not constitute medical advice. Ask your prescriber before starting, stopping, or combining these medicines.